Ana Laus to Prognosis
This is a "connection" page, showing publications Ana Laus has written about Prognosis.
Connection Strength
0.174
-
Freitas AJA, Causin RL, Calfa S, Santana IVV, Balie M, Hirai W, Laus AC, Araujo HS, Hidalgo Filho CM, de Oliveira Bombarda F, da Silva VD, Evangelista AF, de P?dua Souza C, Reis RM, Marques MMC. Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes. Breast Cancer Res Treat. 2025 Jul; 212(2):237-250.
Score: 0.042
-
Sorroche BP, de Jesus Teixeira R, de Souza VG, Tosi IC, Tostes K, Laus AC, Santana IVV, de Lima Vazquez V, Arantes LMRB. CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival. J Mol Med (Berl). 2025 Jun; 103(6):725-737.
Score: 0.042
-
Zantut-Wittmann DE, Barreto IS, Laus AC, Moreno DA, Moma CA, Maia FFR, Assump??o LVMD, Reis RM. PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma. Mol Cell Endocrinol. 2023 06 15; 570:111931.
Score: 0.037
-
Marczynski GT, Laus AC, Dos Reis MB, Reis RM, Vazquez VL. Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients. Sci Rep. 2020 10 29; 10(1):18682.
Score: 0.031
-
Sim?es-Sousa S, Granja S, Pinheiro C, Fernandes D, Longatto-Filho A, Laus AC, Alves CD, Su?rez-Pe?aranda JM, P?rez-Say?ns M, Lopes Carvalho A, Schmitt FC, Garc?a-Garc?a A, Baltazar F. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors. Cell Cycle. 2016 07 17; 15(14):1865-73.
Score: 0.023